Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6070)
All Articles published online
|
Publishing Process of This Article
|
Feb 21, 2013 (publication date) through Nov 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Halpin SJ, Hamlin PJ, Greer DP, Warren L, Ford AC. Efficacy of infliximab in acute severe ulcerative colitis: A single-centre experience. World J Gastroenterol 2013; 19(7): 1091-1097 [PMID: 23467174 DOI: 10.3748/wjg.v19.i7.1091] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i7/1091.htm |
| Number | Citing Articles |
| 1 |
Bikash Devaraj, Andreas M. Kaiser. Surgical Management of Ulcerative Colitis in the Era of Biologicals. Inflammatory Bowel Diseases 2015; 21(1): 208 doi: 10.1097/MIB.0000000000000178
|
| 2 |
Christopher F. D. Li Wai Suen, Matthew C. Choy, Peter De Cruz. What to do when traditional rescue therapies fail in acute severe ulcerative colitis. Intestinal Research 2024; 22(4): 397 doi: 10.5217/ir.2024.00003
|
| 3 |
Amy L. Lightner, Scott A. Strong. The ASCRS Textbook of Colon and Rectal Surgery. 2022; : 765 doi: 10.1007/978-3-030-66049-9_45
|
| 4 |
Christopher F D Li Wai Suen, Dean Seah, Matthew C Choy, Peter De Cruz. Factors Associated With Response to Rescue Therapy in Acute Severe Ulcerative Colitis. Inflammatory Bowel Diseases 2024; 30(8): 1389 doi: 10.1093/ibd/izad183
|
| 5 |
Niharika Nalagatla, Katherine Falloon, Gloria Tran, Nienke Z. Borren, Danny Avalos, Jay Luther, Francis Colizzo, John Garber, Hamed Khalili, Joanna Melia, Matthew Bohm, Ashwin N. Ananthakrishnan. Effect of Accelerated Infliximab Induction on Short- and Long-term Outcomes of Acute Severe Ulcerative Colitis: A Retrospective Multicenter Study and Meta-analysis. Clinical Gastroenterology and Hepatology 2019; 17(3): 502 doi: 10.1016/j.cgh.2018.06.031
|
| 6 |
Jeanne Tung, Felicity T. Enders, Edward V. Loftus. Response to: Infliximab three-dose induction regimen in severe corticosteroid-refractory ulcerative colitis: Early and late outcome and predictors of colectomy. Journal of Crohn's and Colitis 2014; 8(10): 1327 doi: 10.1016/j.crohns.2014.02.020
|
| 7 |
Yoichiro Nuki, Motohiro Esaki, Kouichi Asano, Yuji Maehata, Junji Umeno, Tomohiko Moriyama, Shotaro Nakamura, Takayuki Matsumoto, Takanari Kitazono. Comparison of the therapeutic efficacy and safety between tacrolimus and infliximab for moderate-to-severe ulcerative colitis: a single center experience. Scandinavian Journal of Gastroenterology 2016; 51(6): 700 doi: 10.3109/00365521.2016.1138239
|
| 8 |
Javier P Gisbert, María José García, María Chaparro. Rescue Therapies for Steroid-refractory Acute Severe Ulcerative Colitis: A Review. Journal of Crohn's and Colitis 2023; 17(6): 972 doi: 10.1093/ecco-jcc/jjad004
|
| 9 |
J.‐H. Chen, J. M. Andrews, V. Kariyawasam, N. Moran, P. Gounder, G. Collins, A. J. Walsh, S. Connor, T. W. T. Lee, C. E. Koh, J. Chang, S. Paramsothy, S. Tattersall, D. A. Lemberg, G. Radford‐Smith, I. C. Lawrance, A. McLachlan, G. T. Moore, C. Corte, P. Katelaris, R. W. Leong. Review article: acute severe ulcerative colitis – evidence‐based consensus statements. Alimentary Pharmacology & Therapeutics 2016; 44(2): 127 doi: 10.1111/apt.13670
|
| 10 |
Tsz Hong Yiu, Yanna Ko, Aviv Pudipeddi, Patrizia Natale, Rupert W. Leong. Meta‐analysis: Persistence of advanced therapies in the treatment of inflammatory bowel disease. Alimentary Pharmacology & Therapeutics 2024; 59(11): 1312 doi: 10.1111/apt.18006
|
| 11 |
Javier P. Gisbert, María Chaparro. Acute severe ulcerative colitis: State of the art treatment. Best Practice & Research Clinical Gastroenterology 2018; : 59 doi: 10.1016/j.bpg.2018.05.007
|
| 12 |
Kymberley Thorne, Laith Alrubaiy, Ashley Akbari, David G. Samuel, Sian Morrison-Rees, Stephen E. Roberts. Colectomy rates in patients with ulcerative colitis following treatment with infliximab or ciclosporin. European Journal of Gastroenterology & Hepatology 2016; 28(4): 369 doi: 10.1097/MEG.0000000000000568
|
| 13 |
Marina Aloi, Giulia D’Arcangelo, Martina Capponi, Federica Nuti, Francesca Vassallo, Fortunata Civitelli, Salvatore Oliva, Giuseppe Pagliaro, Salvatore Cucchiara. Managing paediatric acute severe ulcerative colitis according to the 2011 ECCO-ESPGHAN guidelines: Efficacy of infliximab as a rescue therapy. Digestive and Liver Disease 2015; 47(6): 455 doi: 10.1016/j.dld.2015.01.156
|
| 14 |
M. B. Sprakes, P. J. Hamlin. Commentary: salvage medical therapy for acute severe colitis - ciclosporin or infliximab?. Alimentary Pharmacology & Therapeutics 2013; 38(8): 988 doi: 10.1111/apt.12436
|
| 15 |
Catherine Dong, Marie Metzger, Einar Holsbø, Vittorio Perduca, Franck Carbonnel. Systematic review with meta‐analysis: mortality in acute severe ulcerative colitis. Alimentary Pharmacology & Therapeutics 2020; 51(1): 8 doi: 10.1111/apt.15592
|
| 16 |
Jeff Chang, Rupert WL Leong. Occupational health and safety of anti-tumour necrosis factor alpha monoclonal antibodies with casual exposure. Expert Opinion on Biological Therapy 2014; 14(1): 27 doi: 10.1517/14712598.2014.853738
|
| 17 |
Marcus Harbord, Rami Eliakim, Dominik Bettenworth, Konstantinos Karmiris, Konstantinos Katsanos, Uri Kopylov, Torsten Kucharzik, Tamás Molnár, Tim Raine, Shaji Sebastian, Helena Tavares de Sousa, Axel Dignass, Franck Carbonnel. Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management. Journal of Crohn's and Colitis 2017; 11(7): 769 doi: 10.1093/ecco-jcc/jjx009
|
| 18 |
Matthew C Choy, Dean Seah, David M Faleck, Shailja C Shah, Che-Yung Chao, Yoon-Kyo An, Graham Radford-Smith, Talat Bessissow, Marla C Dubinsky, Alexander C Ford, Leonid Churilov, Neville D Yeomans, Peter P De Cruz. Systematic Review and Meta-analysis: Optimal Salvage Therapy in Acute Severe Ulcerative Colitis. Inflammatory Bowel Diseases 2019; 25(7): 1169 doi: 10.1093/ibd/izy383
|
| 19 |
David T. Rubin, Ashwin N. Ananthakrishnan, Corey A. Siegel, Bryan G. Sauer, Millie D. Long. ACG Clinical Guideline: Ulcerative Colitis in Adults. American Journal of Gastroenterology 2019; 114(3): 384 doi: 10.14309/ajg.0000000000000152
|
| 20 |
|
| 21 |
G. Pellino, D. S. Keller, G. M. Sampietro, M. Carvello, V. Celentano, C. Coco, F. Colombo, A. Geccherle, G. Luglio, M. Rottoli, M. Scarpa, G. Sciaudone, G. Sica, L. Sofo, R. Zinicola, S. Leone, S. Danese, A. Spinelli, G. Delaini, F. Selvaggi, Imerio Angriman, Paola Caprino, Francesca Di Candido, Mirko Di Ruscio, Silvio Laureti, Gilberto Poggioli, Gianluca Rizzo, Giulia Roda, Franco Sacchetti, Stefano Scaringi, Bruno Sensi, Angela Variola, Committee Gianluca Pellino, Deborah S. Keller, Gianluca M. Sampietro, Salvatore Leone, Silvio Danese, Antonino Spinelli, GianGaetano Delaini, Francesco Selvaggi. Inflammatory bowel disease position statement of the Italian Society of Colorectal Surgery (SICCR): ulcerative colitis. Techniques in Coloproctology 2020; 24(5): 397 doi: 10.1007/s10151-020-02175-z
|
| 22 |
Enayatullah Baki, Philipp Zwickel, Anna Zawierucha, Robert Ehehalt, Daniel Gotthardt, Wolfgang Stremmel, Annika Gauss. Real-life outcome of anti-tumor necrosis factor α in the ambulatory treatment of ulcerative colitis. World Journal of Gastroenterology 2015; 21(11): 3282-3290 doi: 10.3748/wjg.v21.i11.3282
|
| 23 |
A. Croft, A. Walsh, J. Doecke, G. Radford-Smith. Commentary: salvage medical therapy for acute severe colitis - ciclosporin or infliximab? Author's reply. Alimentary Pharmacology & Therapeutics 2013; 38(8): 989 doi: 10.1111/apt.12475
|